Publications

BibTex format

@article{HIV:2012:10.1371/journal.pmed.1001259,
author = {HIV, Modelling Consortium Treatment as Prevention Editorial Writing Group},
doi = {10.1371/journal.pmed.1001259},
journal = {PLOS Medicine},
title = {HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.},
url = {http://dx.doi.org/10.1371/journal.pmed.1001259},
volume = {9},
year = {2012}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Antiretroviral therapy (ART) for those infected with HIV can prevent onward transmission of infection, but biological efficacy alone is not enough to guide policy decisions about the role of ART in reducing HIV incidence. Epidemiology, economics, demography, statistics, biology, and mathematical modelling will be central in framing key decisions in the optimal use of ART. PLoS Medicine, with the HIV Modelling Consortium, has commissioned a set of articles that examine different aspects of HIV treatment as prevention with a forward-looking research agenda. Interlocking themes across these articles are discussed in this introduction. We hope that this article, and others in the collection, will provide a foundation upon which greater collaborations between disciplines will be formed, and will afford deeper insights into the key factors involved, to help strengthen the support for evidence-based decision-making in HIV prevention.
AU  - HIV,Modelling Consortium Treatment as Prevention Editorial Writing Group
DO  - 10.1371/journal.pmed.1001259
PY  - 2012///
SN  - 1549-1277
TI  - HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.
T2  - PLOS Medicine
UR  - http://dx.doi.org/10.1371/journal.pmed.1001259
UR  - http://www.ncbi.nlm.nih.gov/pubmed/22802739
UR  - http://hdl.handle.net/10044/1/48994
VL  - 9
ER  -

Download

DrBrittaJewell

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)